Intranasal Ketamine for the Management of Incidental Pain during Wound Dressing in Cancer Patients: A Pilot Study

Introduction: Cancer wounds need regular dressing; else they develop infection, foul odor, and in extreme cases, maggots. Patients resist dressing due to the severe incidental pain during dressing. Intranasal ketamine was tried as an analgesic to reduce this incidental pain. Materials and Methods: Twenty patients with wounds requiring regular dressing were selected; these patients had a basal pain score of 4/10 and incidental pain score of 7/10 during four consecutive dressings. Ketamine 0.5 mg/kg was administered transmucosally 10 min before dressing, and pain scores, hemodynamic parameters, and sedation were recorded for up to 2 h in six consecutive dressings. Results: Ketamine produced a significant reduction in incidental pain without any hemodynamic changes or sedation. Conclusion: Ketamine appears to be a safe and effective analgesic when used intranasally for incidental pain.

• Publication year

  2018

• Venue

  Indian Journal of Palliative Care

• Publication date

  2018-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.4103/IJPC.IJPC_143_17PMID 29440808PMCID 5801631
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• P243 Reliability and utility of the Ramsay sedation scale for dosing sedatives in critically ill intubated patients

  2017cited by this paper
• The relationship between malignant wound status and pain in breast cancer patients.

  2016cited by this paper
• Ketamine: A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthesia and Pain Therapy

  2016cited by this paper
• Palliative Wound Care for Malignant Fungating Wounds: Holistic Considerations at End-of-Life.

  2016cited by this paper
• Off-label use of transmucosal ketamine as a rapid-acting antidepressant: a retrospective chart review

  2015cited by this paper
• Burn wound healing and treatment: review and advancements

  2015cited by this paper
• Ketamine for chronic pain: risks and benefits

  2014cited by this paper
• Pain related to cancer treatments and diagnostic procedures: a no man's land?

  2014cited by this paper
• Ketamine: Current applications in anesthesia, pain, and critical care

  2014cited by this paper
• Ketamine as the prototype glutamatergic antidepressant: pharmacodynamic actions, and a systematic review and meta-analysis of efficacy

  2014cited by this paper
• Ketamine Pharmacology: An Update (Pharmacodynamics and Molecular Aspects, Recent Findings)

  2013cited by this paper
• Symptom burden and quality of life in patients with malignant fungating wounds.

  2012cited by this paper
• A systematic review of ketamine as an analgesic agent in adult burn injuries.

  2011cited by this paper
• Adverse events associated with ketamine for procedural sedation in adults.

  2008cited by this paper
• Management of malignant fungating wounds in advanced cancer.

  2006cited by this paper
• Comment on: Bell RF, Kalso K. Is intranasal ketamine an appropriate treatment for chronic non-cancer breakthrough pain? Pain 2004;108:1–2

  2004cited by this paper
• Is intranasal ketamine an appropriate treatment for chronic non-cancer breakthrough pain?

  2004cited by this paper
• Neurophysiology of pain

  2003cited by this paper
• Cancer pain classification

  1997cited by this paper
• The neurophysiology of pain.

  1989cited by this paper

• Treatment Algorithm for Cancerous Wounds: A Systematic Review

  2022cites this paper
• Ketamine Compared With Fentanyl for Surgical Abortion

  2022cites this paper
• Dissociative symptoms with intravenous ketamine in treatment-resistant depression exploratory observational study

  2021cites this paper
• Case Report: Repeated Series of Ketamine Infusions in Patients With Treatment-Resistant Depression: Presentation of Five Cases

  2021cites this paper